HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Panniculitis induced by a chemotherapy regimen consisting of topotecan and cyclophosphamide.

AuthorsErol Kismet, Erkan Demirkaya, Vedat Koseoglu, Salih Deveci, Abdullah Avni Atay
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 44 Issue 1 Pg. 98-9 (Jan 2005) ISSN: 1545-5009 [Print] United States
PMID15368545 (Publication Type: Case Reports, Letter)
Chemical References
  • Topotecan
  • Cyclophosphamide
  • Mesna
Topics
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Humans
  • Infant
  • Male
  • Mesna (administration & dosage, pharmacology)
  • Neoplasms, Germ Cell and Embryonal (drug therapy)
  • Panniculitis (chemically induced, pathology)
  • Topotecan (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: